Information from Industry-Sponsored Supplement
Article

Cervical Cancer Screening in the Post-Vaccine Era – Confronting a New Clinical Reality

Publish date: April 1, 2023
Developed under the direction and sponsorship of Becton Dickinson. This content was peer reviewed by OBG Management

 

In this supplement to OBG Management Phillip D. Stephenson, D.O. Difier Morel, Ph.D and Laurence M. Vaughan, Ph.D. discuss how the ASCCP cervical cancer screening management guidelines were updated in 2019 and utilize a new precision medicine, risk-based approach to patient management.

 

To read more click here 

Recommended Reading

Breast conservation safe even with multiple-site tumors
MDedge ObGyn
FDA approves OTC naloxone, but will cost be a barrier?
MDedge ObGyn
Surgical management of borderline ovarian tumors, part 1
MDedge ObGyn
Sweaty treatment for social anxiety could pass the sniff test
MDedge ObGyn
FDA panels vote to modify isotretinoin iPLEDGE REMS
MDedge ObGyn
Spotting STIs: Vaginal swabs work best
MDedge ObGyn
‘Excess’ deaths surging, but why?
MDedge ObGyn
The physician as leader
MDedge ObGyn
‘Startling’ cost barriers after abnormal screening mammogram
MDedge ObGyn
Frustration over iPLEDGE evident at FDA meeting
MDedge ObGyn